Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Clinical Trials Market in Russia

Clinical Trials Market in Russia

Ratings: (0)|Views: 20|Likes:
Published by radheshyam08
The report Clinical Trials Market in Russia covers various key clinical research companies and sponsors of clinical studies in the country
The report Clinical Trials Market in Russia covers various key clinical research companies and sponsors of clinical studies in the country

More info:

Published by: radheshyam08 on Jul 09, 2010
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as DOC, PDF, TXT or read online from Scribd
See more
See less

10/25/2012

pdf

text

original

 
Clinical Trials Market in Russia
Russia is considered as one the fastest emerging pharma markets in the world.The demand for drugs and pharmaceuticals in the country has increased over the last few years. This has attracted many pharmaceutical companies from allover the world to come and invest in the sector. In line with this trend, the clinicaltrial industry in the country has also registered a positive growth over the pastfew years.In 2009, the number of clinical trials conducted in the country reached around577, an increase of 14% over 2006. These numbers are further expected toreach around 700 by 2012 end. The factors promoting this growth largely includehigh patient recruitment rate, increasing prevalence of diseases, high qualitystandards of clinical studies and low cost of clinical trials in comparison toAmerican and European countries. The same factors are expected to drive thefuture industry growth.The regulatory standard of the clinical trial industry in the country is quite high.The regulatory mandates to adopt GCP standards in the general industrypractice and this has improved the quality level of clinical studies and results.Besides, safety issues are also taken care by the regulatory body, which involvepatient safety, data safety and accuracy concerns. These measures havesignificantly strengthened the overall structure of the industry. Besides, thesehigh patient safety standards have also increased the patient enrolment rate inthe country in various therapies segments.
Clinical Trials Market in Russia
” provides a prudent analysis of the overallclinical trial industry potential. The report also covers various key clinicalresearch companies and sponsors of clinical studies in the country. This will helpour clients in understanding the overall market dynamics. The report will proveuseful and work as an investment guide for those clients who are looking toinvest in the Russian clinical trial industry or conduct their clinical trials in Russia.
Table of content
1. Analyst View2. Research Methodology3. Russian Clinical Trial Industry - An Overview
 
4. Key Market Trends4.1 Niche Therapies Segment4.2 Emerging Economies4.3 Improving Regulatory Environment4.4 Technical Expertise and Quality Practices5. Industry Performance5.1 Clinical Trials5.2 Global Clinical Trial Study5.3 Trials in Advanced Phases5.4 Trials under Major Therapy Areas5.5 Multinational Sponsors6. Regulatory Environment7. Clinical Trial Cost Analysis7.1 Lab Fees7.2 Hourly Rate of CRO8. Patient Profile and Recruitment Analysis8.1 Population8.2 Disease Profile8.3 Patient Recruitment8.4 Patient Recruitment Rate9. Competitive Landscape9.1 Quintiles9.2 PSI Co Ltd9.3 Clinstar 9.4 Parexel9.5 ICON
List of Figures:
Figure 5-1: Number of Clinical Trials (2006-2012)Figure 5-2: Share of Study Type in Clinical Trials (2009)Figure 5-3: Structure of Clinical Trial Market by Study Type (%), 2009Figure 5-4: Number of Clinical Trials by Phase (2008 & 2009)Figure 5-5: Clinical Trials by Therapy Area (%), 2009Figure 5-6: Share of International Sponsors in Clinical Trials by Phase (2009)Figure 8-1: Population Breakup by Age Group (%), 2009Figure 8-2: Share of Population and Clinical Trials by RegionFigure 8-3: Leading Causes of Death (%), 2005 & 2030Figure 8-4: Number of Patients by Study Phase (%), 2009

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->